Tapewire

NYSE · USD

OGEN

ORAGENICS INC

Export transactions ↓
Tapewire entity
8495
SEC CIK
0001174940
Parsed reports
131

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 01, 2026 Filed Jul 7, 2026 21:51 UTC
Spencer JohnChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 55,900 $0.00 Strike: $0.59 $0.00
Disclosure

SEC source: 0002144116-26-000005 · primary_doc.xml · derivative · entry 1

Spencer John · CIK 0002144116 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,900

Underlying: Common Stock · 55,900 shares

Expires 2036-07-01

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One fifth of the options vest on the grant date and the remainder of the options subsequently vest in equal annual installments over the first, second, third and fourth anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 12, 2025 Filed Dec 15, 2025 21:38 UTC
Telling FredDirector
SaleCommon Stock 210 $0.94 $198.37
Disclosure

SEC source: 0001382225-25-000002 · primary_doc.xml · nonDerivative · entry 1

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,538

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
December 12, 2025 Filed Jan 22, 2026 18:04 UTC Amendment
Telling FredDirector
SaleCommon Stock 210 $0.94 $198.37
Disclosure

SEC source: 0001382225-26-000001 · primary_doc.xml · nonDerivative · entry 1

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: This Amendment is being filed to correct the amount of securities beneficially owned. The Issuer effected a 1-for-30 reverse stock split of its outstanding common stock, which was not reflected on the prior Form 4.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 16:12 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001136354-25-000002 · primary_doc.xml · derivative · entry 1

POPE CHARLES L · CIK 0001136354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:55 UTC
Huffman JanetCEO and CFO
GrantEmployee Stock Option (right to buy) · Derivative 250,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001866284-25-000002 · primary_doc.xml · derivative · entry 1

Huffman Janet · CIK 0001866284 · CEO and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:49 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001315585-25-000003 · primary_doc.xml · derivative · entry 2

Giordano Natasha · CIK 0001315585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F2 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F2 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F2 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F2 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:49 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 38,320 $0.00 Strike: $1.03 $0.00
Disclosure

SEC source: 0001315585-25-000003 · primary_doc.xml · derivative · entry 1

Giordano Natasha · CIK 0001315585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,320

Underlying: Common Stock · 38,320 shares

Expires 2035-12-11

F1 · security: Represents an initial equity award upon appointment to the Company's board of directors (the "Board") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025.

F1 · shares: Represents an initial equity award upon appointment to the Company's board of directors (the "Board") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025.

F1 · derivative.exercise_date: Represents an initial equity award upon appointment to the Company's board of directors (the "Board") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025.

F1 · balance_after: Represents an initial equity award upon appointment to the Company's board of directors (the "Board") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:31 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001200155-25-000004 · primary_doc.xml · derivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:38 UTC
Telling FredDirector
GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001382225-25-000002 · primary_doc.xml · derivative · entry 2

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F2 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F2 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F2 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F2 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:25 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001304773-25-000003 · primary_doc.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:19 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001234880-25-000002 · primary_doc.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 11, 2025 Filed Jan 22, 2026 18:04 UTC Amendment
Telling FredDirector
GrantNon-Employee Director Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0001382225-26-000001 · primary_doc.xml · derivative · entry 2

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-12-11

F3 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F3 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F3 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
June 18, 2025 Filed Jun 18, 2025 21:10 UTC SaleCommon Stock - OGEN 5,044 $4.26 $21,487.44
Disclosure

SEC source: 0001683168-25-004612 · ownership.xml · nonDerivative · entry 2

Odyssey Health, Inc. · CIK 0001626644 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
June 17, 2025 Filed Jun 18, 2025 21:10 UTC SaleCommon Stock - OGEN 2,000 $4.46 $8,920.00
Disclosure

SEC source: 0001683168-25-004612 · ownership.xml · nonDerivative · entry 1

Odyssey Health, Inc. · CIK 0001626644 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,044

Read SEC document
June 16, 2025 Filed Jun 16, 2025 22:01 UTC SaleCommon Stock - OGEN 5,000 $4.45 $22,250.00
Disclosure

SEC source: 0001683168-25-004526 · ownership.xml · nonDerivative · entry 2

Odyssey Health, Inc. · CIK 0001626644 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,044

Read SEC document
June 13, 2025 Filed Jun 16, 2025 22:01 UTC SaleCommon Stock - OGEN 5,000 $4.27 $21,350.00
Disclosure

SEC source: 0001683168-25-004526 · ownership.xml · nonDerivative · entry 1

Odyssey Health, Inc. · CIK 0001626644 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,044

Read SEC document
December 11, 2024 Filed Dec 13, 2024 21:05 UTC ConversionSeries B Convertible Preferred Stock · Derivative 1,500,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-049989 · ownership.xml · derivative · entry 3

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F3 · price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F3 · derivative.exercise_date: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F3 · derivative.expiration_date: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F2 · derivative.underlying_shares: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 21:05 UTC ConversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-049989 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 23,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · shares: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · price: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · price: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F3 · price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.

F1 · balance_after: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · balance_after: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · ownership.direct: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · ownership.direct: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

F1 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F2 · ownership.nature: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 23:07 UTC SaleCommon Stock 66 $0.36 $23.76
Disclosure

SEC source: 0001493152-24-049325 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,623

Read SEC document
December 06, 2024 Filed Dec 9, 2024 21:23 UTC
Telling FredDirector
SaleCommon Stock 3,597 $0.36 $1,294.92
Disclosure

SEC source: 0001493152-24-049278 · ownership.xml · nonDerivative · entry 1

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,748

Read SEC document
September 19, 2024 Filed Sep 20, 2024 21:15 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037732 · ownership.xml · derivative · entry 1

POPE CHARLES L · CIK 0001136354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC
Huffman JanetChief Financial Officer
GrantEmployee Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037730 · ownership.xml · derivative · entry 1

Huffman Janet · CIK 0001866284 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC GrantEmployee Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037733 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. The option shares vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037729 · ownership.xml · derivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037728 · ownership.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037731 · ownership.xml · derivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037727 · ownership.xml · derivative · entry 1

Cassidy Bruce A. Sr. · CIK 0001484879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 27,083 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037726 · ownership.xml · derivative · entry 1

Murphy Kimberly M · CIK 0001810474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,083

Underlying: Common Stock · 27,083 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
September 19, 2024 Filed Sep 21, 2024 01:15 UTC
Telling FredDirector
GrantNon-Employee Director Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001493152-24-037734 · ownership.xml · derivative · entry 1

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2034-09-19

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 28, 2023 Filed Jan 2, 2024 22:09 UTC GrantEmployee Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $5.40 $0.00
Disclosure

SEC source: 0001493152-24-000124 · ownership.xml · derivative · entry 1

REDMOND J MICHAEL · CIK 0001200166 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-12-28

F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, in connection with the Reporting Person's engagement to serve as the Company's President. 37,500 options shall vest on the December 28, 2023, the effective date of the Reporting Person's Employment Agreement with the Company (the "Effective Date"), 18,750 options shall vest on June 24, 2024, and 18,750 options shall vest on the first anniversary of the Effective Date, in each case provided the Reporting Person has remained in continuous employment with the Company through such dates. The option exercise price is the Company's closing price on the date of grant.

F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, in connection with the Reporting Person's engagement to serve as the Company's President. 37,500 options shall vest on the December 28, 2023, the effective date of the Reporting Person's Employment Agreement with the Company (the "Effective Date"), 18,750 options shall vest on June 24, 2024, and 18,750 options shall vest on the first anniversary of the Effective Date, in each case provided the Reporting Person has remained in continuous employment with the Company through such dates. The option exercise price is the Company's closing price on the date of grant.

F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, in connection with the Reporting Person's engagement to serve as the Company's President. 37,500 options shall vest on the December 28, 2023, the effective date of the Reporting Person's Employment Agreement with the Company (the "Effective Date"), 18,750 options shall vest on June 24, 2024, and 18,750 options shall vest on the first anniversary of the Effective Date, in each case provided the Reporting Person has remained in continuous employment with the Company through such dates. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
November 30, 2023 Filed Dec 1, 2023 22:23 UTC
Telling FredDirector
SaleCommon Stock 3,500 $3.57 $12,488.35
Disclosure

SEC source: 0001493152-23-043456 · ownership.xml · nonDerivative · entry 1

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,345

Read SEC document
October 04, 2023 Filed Oct 6, 2023 20:33 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 5,102 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001493152-23-036522 · ownership.xml · derivative · entry 1

GANDOLFO JOHN P · CIK 0001200155 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,102

Underlying: Common Stock · 5,102 shares

Expires 2033-10-04

F1 · security: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.

F1 · derivative.exercise_date: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.

F1 · balance_after: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.

Read SEC document
October 04, 2023 Filed Oct 6, 2023 20:31 UTC GrantNon-Employee Director Option (Right to Buy) · Derivative 5,102 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001493152-23-036519 · ownership.xml · derivative · entry 1

Cassidy Bruce A. Sr. · CIK 0001484879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,102

Underlying: Common Stock · 5,102 shares

Expires 2033-10-04

F1 · security: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.

F1 · derivative.exercise_date: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.

F1 · balance_after: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 16:30 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027581 · ownership.xml · nonDerivative · entry 1

POPE CHARLES L · CIK 0001136354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,471

F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC
Murphy Kimberly MDirector · CEO and President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027580 · ownership.xml · nonDerivative · entry 1

Murphy Kimberly M · CIK 0001810474 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

F1 · shares: Represents an award of restricted stock of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with serving as the Company President and Chief Executive Officer with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027579 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,689

F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027577 · ownership.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,689

F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC
Huffman JanetCFO, Secretary and Treasurer
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027578 · ownership.xml · nonDerivative · entry 1

Huffman Janet · CIK 0001866284 · CFO, Secretary and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · shares: Represents an award of restricted stock of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with serving as the Company Secretary, Treasurer and Chief Financial Officer with 10,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:30 UTC
Telling FredDirector
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-027582 · ownership.xml · nonDerivative · entry 1

Telling Fred · CIK 0001382225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,845

F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months.

F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023

Read SEC document
August 08, 2023 Filed Jan 22, 2024 22:30 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003332 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,940

F1 · balance_after: This Form 5 is being filed by the Reporting Person to correct an administrative error, which incorrectly reported the number of shares of Common Stock as beneficially owned by the Reporting Person.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 21:31 UTC
Huffman JanetCFO, Secretary and Treasurer
GrantEmployee Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $4.00 $0.00
Disclosure

SEC source: 0001493152-23-007010 · ownership.xml · derivative · entry 1

Huffman Janet · CIK 0001866284 · CFO, Secretary and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2033-03-07

F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company's Chief Financial Officer. The options vest as follows: 1,400 options vest on the grant date, 1,400 options vest on September 7, 2023, 1,400 options vest on March 7, 2024, 1,400 options vest on September 7, 2024, and 1,400 options vest on March 7, 2025. The option exercise price is the Company's closing price on the date of grant.

F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company's Chief Financial Officer. The options vest as follows: 1,400 options vest on the grant date, 1,400 options vest on September 7, 2023, 1,400 options vest on March 7, 2024, 1,400 options vest on September 7, 2024, and 1,400 options vest on March 7, 2025. The option exercise price is the Company's closing price on the date of grant.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 21:20 UTC SaleCommon Stock 42,357 $0.11 $4,468.66
Disclosure

SEC source: 0001493152-23-000130 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,102,295

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 29, 2022 Filed Jan 3, 2023 21:20 UTC SaleCommon Stock 36,648 $0.11 $3,884.69
Disclosure

SEC source: 0001493152-23-000130 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,191

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:05 UTC SaleCommon Stock 140,497 $0.18 $24,699.37
Disclosure

SEC source: 0001493152-22-035732 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,144,652

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 14, 2022 Filed Dec 15, 2022 21:15 UTC SaleCommon Stock 4,503 $0.18 $788.03
Disclosure

SEC source: 0001493152-22-035570 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,310,149

F1 · price: The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:05 UTC SaleCommon Stock 25,000 $0.18 $4,375.00
Disclosure

SEC source: 0001493152-22-035732 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,285,149

F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 09, 2022 Filed Dec 12, 2022 21:22 UTC SaleCommon Stock 48,795 $0.20 $9,612.62
Disclosure

SEC source: 0001493152-22-035184 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,314,652

F1 · price: The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1750 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
December 08, 2022 Filed Dec 9, 2022 21:14 UTC SaleCommon Stock 13,036 $0.20 $2,607.20
Disclosure

SEC source: 0001493152-22-035043 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,363,447

F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1901 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
November 30, 2022 Filed Dec 1, 2022 21:08 UTC SaleCommon Stock 200,000 $0.19 $38,220.00
Disclosure

SEC source: 0001493152-22-034167 · ownership.xml · nonDerivative · entry 2

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,376,483

F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document
November 29, 2022 Filed Dec 1, 2022 21:08 UTC SaleCommon Stock 200,000 $0.19 $38,460.00
Disclosure

SEC source: 0001493152-22-034167 · ownership.xml · nonDerivative · entry 1

KOSKI ROBERT C · CIK 0001234880 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,576,483

F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.